Author:
Yakhkind Aleksandra,Yu Wenzheng,Li Qi,Goldstein Joshua N.,Mayer Stephan A.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. American Heart Association. Phase III Target: Stroke: higher goals for greater good. Accessed May 3, 2024. https://www.heart.org/-/media/files/professional/quality-improvement/target-stroke/target-stroke-phase-iii/ts-phase-iii-5-6-19/final5619-target-stroke-phase-3-brochure.pdf
2. Avan A, Digaleh H, Di Napoli M, Stranges S, Behrouz R, Shojaeianbabaei G, Amiri A, Tabrizi R, Mokhber N, Spence JD, Azarpazhooh MR. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med. 2019;17(1):1–30.
3. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, Abbasifard M, Abbasi-Kangevari M, Abd-Allah F, Abedi V, Abualhasan A. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology. 2021;20(10):795–820.
4. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM, Farmer A. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). The Lancet. 2004;363(9425):1925–33.
5. Zahuranec DB, Lisabeth LD, Sánchez BN, Smith MA, Brown DL, Garcia NM, Skolarus LE, Meurer WJ, Burke JF, Adelman EE, Morgenstern LB. Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology. 2014;82(24):2180–6.